With 0.12 million shares changed hands, the volume of the stock remained heavier than its average volume of 94440.0 shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $2.4 whereas the lowest price it dropped to was $1.97. The 52-week range on APUS shows that it touched its highest point at $4.03 and its lowest point at $1.37 during that stretch.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of APUS was down-trending over the past week, with a drop of -27.72%, but this was up by 7.56% over a month. Three-month performance surged to 17.74% while six-month performance rose 26.59%.
Float and Shares Shorts:
At present, 12.58 million APUS shares are outstanding with a float of 3.09 million shares on hand for trading. On 2025-11-14, short shares totaled 20806.0, which was 17.0 higher than short shares on 1760486400. In addition to Dr. Christopher M. H. Kim M.D. as the firm’s Chief Medical Officer & Chairman, Mr. Erik C. Emerson serves as its CEO & Director.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-09-30, APUS reported revenue of $0.0 and operating income of -$1844239.0. The EBITDA in the recently reported quarter was -$1786324.0 and diluted EPS was -$0.14.
